Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu


Long-acting bronchodilator use by patients with chronic lung disease and risk of acute coronary syndrome in real-world clinical practice

Lianna Parkin and Jack Drummer image 2021 thumb

Wednesday 27 January 2021

The use of two long-acting bronchodilator inhalers to treat chronic obstructive pulmonary disease (COPD) symptoms is associated with a higher risk of acute coronary syndrome (ACS, heart attack or unstable angina) than the use of just one long-acting bronchodilator according to recently published research by investigators from the Pharmacoepidemiology Research Network at the University of Otago.